Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>APOE4</i> and <i>INPP5D</i> converge on membrane mechanics to regulate endocytosis in human astrocytes.

bioRxiv : the preprint server for biology·2026
Same author

Inhibition of chemokine CXCL12 modulates the tumor microenvironment in glioblastoma and potentiates immune checkpoint inhibitor efficacy in a tissue-specific manner.

Neuro-oncology advances·2026
Same author

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial.

Neuro-oncology advances·2026
Same author

CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.

Neuro-oncology advances·2026
Same author

Raman spectroscopy as a diagnostic tool for glioma: protocol for a systematic review.

Diagnostic and prognostic research·2026
Same journal

Inferring DNA Methylation Class from Digitized Pathology Images and AI: A Worthy and Timely Application with Room for Improved Clinical Performance.

Neuro-oncology·2026
Same journal

The clinical and molecular landscape of thalamic glioma.

Neuro-oncology·2026
Same journal

MAPK-driven glioma progression and reprogramming of the tumor-associated immune response.

Neuro-oncology·2026
Same journal

Tumor-Targeted pan-RAS Inhibition as a Novel Biologic Therapy for Diffuse Midline Glioma.

Neuro-oncology·2026
Same journal

Corrigendum to: Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma.

Neuro-oncology·2026
Same journal

Selective histone deacetylase inhibition as a therapeutically relevant strategy in H3K27M-glioma.

Neuro-oncology·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2025

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

313

Raman-based machine-learning platform reveals unique metabolic differences between IDHmut and IDHwt glioma.

Adrian Lita1, Joel Sjöberg2, David Păcioianu3

  • 1National Cancer Institute, National Institutes of Health, Neuro-Oncology Branch, Bethesda, Maryland, USA.

Neuro-Oncology
|June 3, 2024
PubMed
Summary
This summary is machine-generated.

A new computational workflow, APOLLO, uses Raman spectroscopy on FFPE tissue slides to classify glioma subtypes and identify molecular differences. This label-free method extracts valuable biological insights from archived cancer tissues.

Keywords:
FFPE tissueRaman spectroscopygliomalipid metabolismmachine learning

More Related Videos

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

8.1K
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

7.9K

Related Experiment Videos

Last Updated: Jun 24, 2025

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

313
Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

8.1K
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

7.9K

Area of Science:

  • Biomedical Optics
  • Molecular Pathology
  • Computational Biology

Background:

  • Formalin-fixed, paraffin-embedded (FFPE) tissues are crucial for cancer diagnosis and biobanking.
  • Background noise from embedding media has limited FFPE tissue use in Raman spectroscopy.
  • Developing methods to analyze FFPE tissues with Raman spectroscopy is essential for unlocking their full potential.

Purpose of the Study:

  • To develop a computational workflow (APOLLO) for classifying glioma subtypes using Raman spectroscopy on FFPE tissue slides.
  • To identify novel Raman spectral markers for distinguishing glioma subtypes and molecular characteristics.
  • To demonstrate the feasibility of label-free molecular analysis of archived FFPE tissues.

Main Methods:

  • Utilized spontaneous Raman spectroscopy for molecular fingerprinting of 46 FFPE glioma samples.
  • Employed machine learning (SVM, random forest) to build classifiers for tumor/non-tumor, IDH1 status, and methylation subtypes.
  • Validated key Raman frequencies using stimulated Raman spectroscopy and mass spectrometry.

Main Results:

  • Developed APOLLO, a workflow distinguishing tumor from non-tumor FFPE tissue based on Raman spectra.
  • Identified novel Raman peaks associated with DNA and proteins in tumors.
  • Successfully differentiated IDH1 mutant from wild-type gliomas, noting higher cholesterol esters in IDH1 mutant tumors.
  • Achieved high accuracy in classifying clinically relevant glioma methylation subtypes (G-CIMP-high vs. G-CIMP-low).

Conclusions:

  • Label-free Raman spectroscopy can effectively classify glioma subtypes from FFPE slides.
  • APOLLO provides a method to extract meaningful biological information from archived FFPE tissues.
  • This approach holds promise for future applications in analyzing other cancer types using FFPE samples.